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ABSTRACT   
Receiver Operating Characteristic analysis provides a reliable and cost effective performance measurement tool, without 
using full clinical trials. However, when ROC analysis shows that performance is statistically superior in one condition 
than another it is difficult to relate this result to effects in practice, or even to determine whether it is clinically 
significant. In this paper we present two concurrent analyses: using ROC methods alongside single threshold recall rate 
data, and suggest that reporting both provides complimentary data. Four mammographers read 160 difficult cases (41% 
malignant) twice, with and without prior mammograms. Lesion location and probability of malignancy was reported for 
each case and analyzed using JAFROC. Concurrently each participant chose recall or return to screen for each case. 
JAFROC analysis showed that the presence of prior mammograms improved performance (p<.05). Single threshold data 
showed a trend towards a 26% increase in the number of false positive recalls without prior mammograms (p=.056). If 
this trend were present throughout the NHS Breast Screening Programme then discarding prior mammograms would 
correspond to an increase in recall rate from 4.6% to 5.3%, and 12,414 extra women recalled annually for assessment. 
Whilst ROC methods account for all possible thresholds of recall and have higher power, providing a single threshold 
example of false positive, false negative, and recall rates when reporting results could be more influential for clinicians. 
This paper discusses whether this is a useful additional method of presenting data, or whether it is misleading and 
inaccurate.   
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1. INTRODUCTION  
 
When a breast screening centre first upgrades from film to digital mammography they must take a decision of whether to 
continue to present the prior mammograms, which are of course in film format. The research presented here was 
designed to provide information to these breast screening centers so that they can make a more informed choice about 
whether it is worth the effort of hanging these film prior mammograms. This raises a wider question of how evidence 
from ROC studies using enriched case sets should be presented. Providing single threshold sensitivity and specificity 
data makes the data easier for a clinician to apply to a local setting, but is this appropriate considering an enriched data 
set is being used and a single recall threshold must be chosen? 
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Context: Evidence Based Radiology 
 
Clinicians and healthcare managers are increasingly being encouraged to take the approach of evidence based medicine 
in their decision making. An understanding of this process can help researchers produce data which is more useful and 
applicable in decision making. Evidence Based Medicine (EBM) is concerned with systematically analyzing the 
available evidence to make both clinical decisions for individual patients and policy decisions. Evidence Based 
Radiology (EBR) follows similar principles, but Sardanelli et al. [1] describe several ways in which it differs. Firstly the 
need for the decision maker to have an in depth knowledge of the physics of image generation and manipulation, as these 
can have a very large effect on performance measurements. Secondly the high speed of technical developments resulting 
in a lack of time to produce meaningful data concerning the efficacy, effectiveness and cost effectiveness of each 
technology. Finally the harmful effects of the radiation associated with many imaging techniques impacts both the data 
which can be collected, and the technologies which can be implemented.  
 
There are two possible approaches for EBR; top down and bottom up. The bottom up approach involves a practitioner 
for example a radiologist or a manager of a hospital department or screening centre defining a problem that they face 
(either from an individual patient or a policy issue) and finding, appraising and applying the findings from the available 
evidence. This relies on the practitioner having the necessary skills to source, critically analyze, and apply the evidence 
available, but does allow local factors to be considered. Top down EBR relies on institutions with specific expertise to 
systematically review the evidence and produce guidelines for local application. This has the advantages of availability 
of specialized expertise, but may be not directly applicable to a range of clinical situations, and may both be adhered to 
by the practitioner due to lack of involvement in and understanding of the processes involved. Additionally this is a time 
consuming process and therefore not always possible in the fast moving field of radiology. These two approaches are 
shown systematically in figure 1.  
 
The distinction between top down and bottom up approaches is critically important when deciding how to disseminate 
results from a research study, as it determines who is the target recipient, their level of expertise in data analysis and 
appraisal, and their objectives. A large number of decisions in radiology are made at the level of the individual 
institution, where best practice would be use of bottom up evidence based radiology. This paper investigates whether we 
could be presenting research in a format which is of more use to the clinicians and managers making decisions in a 
bottom up manner for their individual institutions. 
 
Clinicians and managers taking the bottom up approach to evidence based radiology must consider not only the efficacy 
of a diagnostic test (performance under ideal conditions), but also its effectiveness (performance in real world 
conditions) and its efficiency (whether it is cost effective versus other treatments). The Standards for Reporting 
Diagnostic Accuracy Studies (STARD)[2] provide an excellent reference to ensure the information is present to enable 
the reader to critically analyse both internal and external validity of the study. However, if results of a diagnostic test are 
presented using ROC curves, and there is a statistically significant difference between conditions, how can a clinician 
determine whether this difference is clinically significant in the context of their institution? The area under an ROC 
curve is equal to the probability that a radiologist will rank a randomly chosen abnormal case higher than a randomly 
chosen normal case. This is, of course, independent of decision threshold. When abnormality location information within 
the image is important, and tools such JAFROC are used, how can the reader interpret the magnitude in the difference in 
figures of merit between different conditions? Should results be extrapolated to ‘real world’ consequences in a specific 
setting i.e. provide false positive and false negative rates at a set threshold? This would render clinical significance easier 
to interpret, but has several associated issues. Should this be extrapolated further to include analysis of costs? There may 
be a trade off between pure scientific integrity and producing results which clinicians and managers taking a bottom up 
approach to EBR would find easier and less time consuming to interpret. 
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Figure 1 - Top down vs bottom up approaches to evidence based medicine. Adapted from Sardanelli (2010) 
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Application of Enriched Case ROC studies to Clinical Practice 
 
There are several potential issues specifically with the application of ROC performance data from human observers 
reading enriched case sets to clinical practice using a set threshold: 
1. The threshold for recall should be the same as that used in practice. Using a significantly different threshold for 
recall than used in practice could significantly affect measures of sensitivity and specificity.  
2. The case set should mirror clinical practice. To ensure ROC results with a small case set it can be enriched with 
difficult cases and an increased number of abnormal cases. However, the test can still mirror clinical practice in 
the proportions of the different types of abnormalities. 
3. The test environment should mirror the clinical environment as closely as possible. The equipment 
specifications and time pressures should be similar.  
 
2. METHODS 
 
Participants and Cases 
 
Four participants from one breast screening centre in the UK took part in the study, two breast specialist radiologists and 
two radiography advanced practitioners. Radiography Advanced Practitioners are radiographers who have been trained 
and qualified to read mammograms in the NHS Breast Screening Programme (NHSBSP). 
 
Each participant read an enriched case set of 160cases. These cases can be classified as follows: 66 abnormal cases 
proven by biopsy; 60 normal cases which had been recalled for further tests in the NHSBSP; 28 normal cases which had 
been arbitrated (i.e. one reader thought it should be recalled and the other did not, so it was referred to a third reader for 
arbitration) in the NHSBSP but not recalled for further tests; and 6 normal cases which were not recalled by either reader 
in the NHSBSP. Of the abnormal cases two had more than one lesion; they two lesions each. 
 
Each participant was asked to mark the locations of any suspicious lesions, rate the probability of malignancy of each 
lesion identified on a scale of 1 to 100%, and state whether they would have recalled the case if they had encountered in 
whilst working in the NHSBSP.  
 
Workstation  
 
The workstation used in this study was digital, mammograms were obtained from the MicroDose Mammography system 
(Sectra, Sweden) and were displayed using Sectra mammography PACS on twin five megapixel LCD screens (EIZO, 
Japan). The previous mammograms were acquired using a Mammomat 3000 Nova (Siemens, Germany), with Kodak 
MIN-R2000 mammography film, and developed using a Kodak X-OMAT Multiloader 7000 (Carestream Health, 
Toronto, Canada). They were displayed on a Mammolux XL multi-viewer (Planilux, Germany), which was positioned 
adjacent and perpendicular to the digital workstation, as shown in figure 2. 
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Figure 2 – The workstation used in the study. The current digital mammograms are displayed to the left on LCD screens 
and the film prior mammograms (when present) are displayed to the right on a multi-viewer. 
 
Analysis 
 
Overall performance was compared in the conditions with prior mammograms and without prior mammograms using 
JAFROC software [3], as is typical for observer performance studies with location information, and cases with more than 
one lesion. An additional analysis of whether the number of normal cases recalled differed between conditions was 
conducted using a within subjects students t test. This was considered a metric which would be of greater interest to 
clinicians. These results were then applied to an example breast screening centre to give a measure of clinical 
significance in one clinical setting. 
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3. RESULTS 
JAFROC Analysis 
 
JAFROC analysis showed that performance in digital mammography was greater with the film prior mammograms 
available and mounted on an adjacent multi-viewer (p<.05). These are illustrated using a FROC curve as shown in figure 
3. This analysis may be considered sufficient for publication, and demonstrates that using the film prior mammograms 
produces a statistically significant improvement. However it may not advise a clinician or manager whether the effort of 
hanging all of the film prior mammograms resulted in a clinically significant improvement.  
 
 
 
Figure 3 – A FROC curve of performance in digital mammography both with and without film prior mammograms. 
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Recall Decision Analysis 
 
The number true positive responses did not differ between conditions i.e. the number of cancers detected did not differ 
between conditions. There was a trend towards a greater number of false positives (26% increase, p=.056) when the prior 
mammograms were not available in comparison to when they were displayed in film format (i.e. a trend towards 
recalling more women who do not have cancer when the prior mammograms are not available). If this trend were present 
throughout the NHS Breast Screening Programme then discarding prior mammograms would correspond to an increase 
in recall rate from 4.6% to 5.3%, and 12,414 extra women recalled annually for assessment. 
 
Figure 4 – The number of normal cases recalled using digital mammography both with and without film prior 
mammograms. 
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4. DISCUSSION 
 
The three requirements outlined in the introduction for applying ROC studies to clinical practice using a single threshold 
were: using the same threshold as in clinical practice; the case set mirroring clinical practice; and the test environment 
mirroring clinical practice.  
 
Using the same threshold as clinical practice appeared straightforward to implement. An extra question was simply 
added for each case asking the participant whether they would have recalled the case in clinical practice. However this 
may not have been an accurate representation of clinical practice as Gur et. al. [4] found that increasing the prevalence of 
disease in the case set was associated with decreases in the readers’ levels of confidence. Therefore even though the 
experimental reporting is identical to that of clinical practice, simply enriching the case set for the test may change the 
radiologists’ threshold for recall. 
 
The case set approximately mirrored that of clinical practice. The proportions of the different types of abnormalities were 
not matched to the proportions experienced in a breast screening programme (i.e. the sampling was not stratified by 
abnormality type), but they were selected at random from the programme. This appears a reasonable approximation. 
 
The test environment closely mirrored clinical practice as it was a workstation in a UK breast screening centre, which all 
participants were familiar with and used during the course of their work. This is as close to mirroring clinical practice as 
is possible, but the fact that the cases are not live screening cases, and that performance is being measured may 
encourage participants to adapt their behavior.  
 
With the rapid introduction of technological advancements in radiology causing time pressures, and the economic 
downturn causing funding pressures, study designs using small numbers of participants reading enriched case sets for 
ROC analysis are increasingly attractive. However, these data are not directly applicable to clinicians taking an EBR 
approach. Extension of reporting to include single threshold sensitivity and specificity data could provide a richer source 
of data more applicable to clinical practice, but further research is needed to assess whether this approach is valid. 
 
5. CONCLUSIONS 
 
Presenting results of ROC studies in terms of single threshold specificity and sensitivity, or false positive and false 
negative rates could help clinicians and healthcare managers determine the clinical significance of the results in addition 
to the statistical significance. However further research is required to determine whether this is an appropriate strategy 
and produces results of sufficient internal and external validity. 
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